Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study

Subclinical Atherosclerosis Risk Can Be Predicted in Female Patients With Systemic Lupus Erythematosus Using Metabolomic Signatures: An Observational Study

Background Cardiovascular disease (CVD) is a leading cause of death in women with systemic lupus erythematosus (SLE) due to accelerated atherosclerosis that is not predicted by established CVD risk scores. This study aimed to develop, validate, and test a female‐focused predictive atherosclerosis ri...

Full description

Saved in:
Bibliographic Details
Main Authors: Laurel Woodridge, Maria G. Tektonidou, George A. Robinson, Junjie Peng, Leda Coelewij, Lucia Martin‐Gutierrez, Elvira Chocano Navarro, Maura Griffin, Andrew Nicolaides, Coziana Ciurtin, Anisur Rahman, Inés Pineda Torra, Elizabeth C. Jury
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiovascular disease risk
female
metabolomics
SLE
subclinical atherosclerosis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.036507
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items